• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

疾病管理项目预防糖尿病肾病的长期效果:利用日本行政数据的倾向评分匹配分析。

Long-term effectiveness of a disease management program to prevent diabetic nephropathy: a propensity score matching analysis using administrative data in Japan.

机构信息

Chronic Care and Family Nursing, Division of Nursing Science, Graduate School of Biomedical and Health Sciences, Hiroshima University, Kasumi 1-2-3, Minami-Ku, Hiroshima, 734-8553, Japan.

Group Business Development Division, Hankyu Hanshin Holdings Inc, Osaka, Japan.

出版信息

BMC Endocr Disord. 2022 May 20;22(1):135. doi: 10.1186/s12902-022-01040-4.

DOI:10.1186/s12902-022-01040-4
PMID:35596152
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9123750/
Abstract

BACKGROUND

Existing reviews indicated that disease management for patients with diabetes may be effective in achieving better health outcomes with less resource utilization in the short term. However, the long-term results were inconsistent because of the heterogeneous nature of the study designs. In the present study, we evaluated the 5-year follow-up results of a local disease management program focused on diabetic nephropathy prevention under the universal public health insurance scheme in Japan.

METHODS

Patients diagnosed with type 2 diabetes who had stage 3 or 4 diabetic kidney disease and were aged between 20 and 75 years were invited to join a disease management program to support self-management and receive a recommended treatment protocol between 2011 and 2013. Follow-up data were collected from an electronic claims database for the public insurance scheme. Considering the non-random selection process, we prepared two control groups matched by estimated propensity scores to compare the incidence of diabetes-related complications, death, and resource utilization.

RESULTS

The treatment group was more likely to receive clinical management in accordance with the guideline-recommended medication. After propensity score matching, the treatment group had lower incidence of diabetic nephropathy and emergency care use than the control group selected from a beneficiary pool mainly under primary care. Comparisons between the treatment group and the control group with more selected clinical conditions did not show differences in the incidence rate and resource utilization.

CONCLUSIONS

The present results demonstrated limited effectiveness of the program for reducing complication incidence and resource utilization during the 5-year follow-up. Further research on the long-term effectiveness of co-management by primary care physicians, subspecialists in endocrinology and nephrology, and nurse educators is required for effective management of diabetes-related nephropathy.

摘要

背景

现有研究表明,针对糖尿病患者的疾病管理可能会在短期内通过减少资源利用实现更好的健康结果。然而,由于研究设计的异质性,长期结果并不一致。在本研究中,我们评估了日本全民健康保险计划下针对糖尿病肾病预防的本地疾病管理项目的 5 年随访结果。

方法

我们邀请患有 3 或 4 期糖尿病肾病且年龄在 20 至 75 岁之间的 2 型糖尿病患者参加疾病管理项目,以支持自我管理并在 2011 年至 2013 年期间接受推荐的治疗方案。随访数据来自公共保险计划的电子索赔数据库。考虑到非随机选择过程,我们准备了两组通过估计倾向得分匹配的对照组,以比较糖尿病相关并发症、死亡和资源利用的发生率。

结果

治疗组更有可能按照指南推荐的药物进行临床管理。经过倾向得分匹配后,与主要在初级保健下选择的对照组相比,治疗组的糖尿病肾病和急诊护理使用率较低。与选择更多临床条件的对照组相比,治疗组的发生率和资源利用没有差异。

结论

本研究结果表明,该项目在 5 年随访期间降低并发症发生率和资源利用的效果有限。需要进一步研究初级保健医生、内分泌和肾脏病学专家以及护士教育者共同管理对糖尿病相关肾病的长期有效性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/336b/9123750/20d9cb85acb7/12902_2022_1040_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/336b/9123750/20d9cb85acb7/12902_2022_1040_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/336b/9123750/20d9cb85acb7/12902_2022_1040_Fig1_HTML.jpg

相似文献

1
Long-term effectiveness of a disease management program to prevent diabetic nephropathy: a propensity score matching analysis using administrative data in Japan.疾病管理项目预防糖尿病肾病的长期效果:利用日本行政数据的倾向评分匹配分析。
BMC Endocr Disord. 2022 May 20;22(1):135. doi: 10.1186/s12902-022-01040-4.
2
The effect of continuity of care on the incidence of end-stage renal disease in patients with newly detected type 2 diabetic nephropathy: a retrospective cohort study.连续性护理对新诊断 2 型糖尿病肾病患者终末期肾病发生率的影响:一项回顾性队列研究。
BMC Nephrol. 2018 Jun 5;19(1):127. doi: 10.1186/s12882-018-0932-3.
3
Evaluation of a program designed to prevent diabetic nephropathy aggravation: A retrospective cohort study using health checkups and claims data in Japanese municipalities.评估一项旨在预防糖尿病肾病恶化的计划:使用日本市政厅健康检查和索赔数据的回顾性队列研究。
Diabetes Res Clin Pract. 2024 Sep;215:111804. doi: 10.1016/j.diabres.2024.111804. Epub 2024 Jul 30.
4
Status of screening and preventive efforts against diabetic kidney disease between 2013 and 2018: analysis using an administrative database from Kyoto-city, Japan.2013 年至 2018 年期间日本京都市糖尿病肾病筛查和预防工作的现状:基于行政数据库的分析。
Front Endocrinol (Lausanne). 2023 Jul 27;14:1195167. doi: 10.3389/fendo.2023.1195167. eCollection 2023.
5
Construction of a simulation model and evaluation of the effect of potential interventions on the incidence of diabetes and initiation of dialysis due to diabetic nephropathy in Japan.构建一个模拟模型,并评估潜在干预措施对日本糖尿病发病率及糖尿病肾病所致透析起始率的影响。
BMC Health Serv Res. 2017 Dec 16;17(1):833. doi: 10.1186/s12913-017-2784-0.
6
Higher incidence of diabetic nephropathy in type 2 than in type 1 diabetes in early-onset diabetes in Japan.在日本早发型糖尿病中,2型糖尿病患者糖尿病肾病的发病率高于1型糖尿病患者。
Kidney Int. 2000 Jul;58(1):302-11. doi: 10.1046/j.1523-1755.2000.00166.x.
7
Fracture risk and healthcare resource utilization and costs among osteoporosis patients with type 2 diabetes mellitus and without diabetes mellitus in Japan: retrospective analysis of a hospital claims database.日本2型糖尿病合并和未合并糖尿病的骨质疏松症患者的骨折风险、医疗资源利用及成本:医院理赔数据库的回顾性分析
BMC Musculoskelet Disord. 2016 Nov 25;17(1):489. doi: 10.1186/s12891-016-1344-9.
8
[Hospital-primary care teamwork in nephrology: 'preventive' epidemiology of diabetic nephropathy].[肾脏病学中的医院-基层医疗团队合作:糖尿病肾病的“预防性”流行病学]
G Ital Nefrol. 2007 Sep-Oct;24 Suppl 38:83-6.
9
Self-efficacy remains a vital factor in reducing the risk of dialysis in type 2 diabetes care.自我效能仍然是降低2型糖尿病护理中透析风险的一个重要因素。
Medicine (Baltimore). 2021 Jul 16;100(28):e26644. doi: 10.1097/MD.0000000000026644.
10
Japan Diabetic Nephropathy Cohort Study: study design, methods, and implementation.日本糖尿病肾病队列研究:研究设计、方法与实施
Clin Exp Nephrol. 2013 Dec;17(6):819-26. doi: 10.1007/s10157-013-0778-8. Epub 2013 Feb 28.

引用本文的文献

1
Reduction in all-cause medical and caregiving costs through innovative health awareness projects in a rural area in Japan: a retrospective cohort study.通过在日本农村地区开展创新的健康意识项目来降低全因医疗和护理费用:一项回顾性队列研究。
BMC Health Serv Res. 2024 Mar 25;24(1):370. doi: 10.1186/s12913-024-10836-0.
2
Experience of humanistic nursing in hemodialysis nursing for patients with diabetic kidney disease.人文护理在糖尿病肾病患者血液透析护理中的应用体会
World J Diabetes. 2024 Feb 15;15(2):186-195. doi: 10.4239/wjd.v15.i2.186.
3
Chronic disease management program applied to type 2 diabetes patients and prevention of diabetic complications: a retrospective cohort study using nationwide data.

本文引用的文献

1
Diabetic kidney disease: update on clinical management and non-glycaemic effects of newer medications for type 2 diabetes.糖尿病肾病:2型糖尿病新型药物临床管理及非血糖效应的最新进展
Ther Adv Endocrinol Metab. 2021 May 29;12:20420188211020664. doi: 10.1177/20420188211020664. eCollection 2021.
2
Cost-effectiveness of Interventions to Manage Diabetes: Has the Evidence Changed Since 2008?干预措施管理糖尿病的成本效益:自 2008 年以来证据是否发生了变化?
Diabetes Care. 2020 Jul;43(7):1557-1592. doi: 10.2337/dci20-0017.
3
Does disease management for diabetic nephropathy reduce medical expenditure? Evidence from a three-period difference-in-differences analysis.
慢性病管理方案应用于 2 型糖尿病患者和预防糖尿病并发症:一项使用全国性数据的回顾性队列研究。
BMC Public Health. 2023 May 23;23(1):928. doi: 10.1186/s12889-023-15763-z.
糖尿病肾病的疾病管理是否降低了医疗支出?来自三时期差分分析的证据。
BMC Health Serv Res. 2020 May 11;20(1):403. doi: 10.1186/s12913-020-05297-0.
4
Diabetic kidney disease: new clinical and therapeutic issues. Joint position statement of the Italian Diabetes Society and the Italian Society of Nephrology on "The natural history of diabetic kidney disease and treatment of hyperglycemia in patients with type 2 diabetes and impaired renal function".糖尿病肾病:新的临床和治疗问题。意大利糖尿病学会和意大利肾脏病学会关于“糖尿病肾病的自然病程和肾功能受损的 2 型糖尿病患者的高血糖治疗”的联合立场声明。
J Nephrol. 2020 Feb;33(1):9-35. doi: 10.1007/s40620-019-00650-x.
5
The associations of multimorbidity with the sum of annual medical and long-term care expenditures in Japan.日本多病共存与年度医疗和长期护理支出总和的关联。
BMC Geriatr. 2019 Mar 7;19(1):69. doi: 10.1186/s12877-019-1057-7.
6
Antipsychotic use and related factors among people with dementia aged 75 years or older in Japan: A comprehensive population-based estimation using medical and long-term care data.抗精神病药物在日本 75 岁及以上痴呆患者中的使用情况及相关因素:基于医疗和长期护理数据的综合人群估算。
Int J Geriatr Psychiatry. 2019 Mar;34(3):472-479. doi: 10.1002/gps.5041. Epub 2018 Dec 27.
7
Implementing personalized medicine in diabetic kidney disease: Stakeholders' perspectives.在糖尿病肾病中实施个性化医疗:利益相关者的观点。
Diabetes Obes Metab. 2018 Oct;20 Suppl 3(Suppl Suppl 3):24-29. doi: 10.1111/dom.13412.
8
Burden of Illness in Type 2 Diabetes Mellitus.2型糖尿病的疾病负担
J Manag Care Spec Pharm. 2018 Sep;24(9-a Suppl):S5-S13. doi: 10.18553/jmcp.2018.24.9-a.s5.
9
Five-Year Effectiveness of the Multidisciplinary Risk Assessment and Management Programme-Diabetes Mellitus (RAMP-DM) on Diabetes-Related Complications and Health Service Uses-A Population-Based and Propensity-Matched Cohort Study.基于人群和倾向匹配队列研究:多学科风险评估和管理方案-糖尿病(RAMP-DM)对糖尿病相关并发症和卫生服务利用的 5 年效果。
Diabetes Care. 2018 Jan;41(1):49-59. doi: 10.2337/dc17-0426. Epub 2017 Nov 14.
10
Metformin for diabetes prevention: insights gained from the Diabetes Prevention Program/Diabetes Prevention Program Outcomes Study.二甲双胍预防糖尿病:来自糖尿病预防计划/糖尿病预防计划结果研究的新见解。
Diabetologia. 2017 Sep;60(9):1601-1611. doi: 10.1007/s00125-017-4361-9. Epub 2017 Aug 2.